Komipharm International Co., Ltd. (041960.KQ)
KRW 3815.0
(-1.55%)
KRW 3815.0
(-1.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -2.79 Billion | -1.8 Billion | -1.25 Billion | 25.2 Million | 950.79 Million |
| Net Income | -5.91 Billion | -7.47 Billion | -5.93 Billion | -3.95 Billion | -21.36 Billion |
| Depreciation & Amortization | 3.52 Billion | 3.82 Billion | 3.58 Billion | 3.73 Billion | 3.85 Billion |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 26.88 Million | 115.45 Million | 115.45 Million | 139.09 Million | 225.23 Million |
| Change in working capital | -62.21 Million | -2.48 Billion | -343.85 Million | -1.03 Billion | 1.49 Billion |
| Other non-cash items | 1.73 Billion | 1.99 Billion | 1.61 Billion | 1.19 Billion | 16.73 Billion |
| Investing Cash Flow | -3.5 Billion | -1.37 Billion | -744.84 Million | -1.56 Billion | -6.56 Billion |
| Investments in PPE | -1.12 Billion | -1.06 Billion | -1.18 Billion | -1.68 Billion | -5.73 Billion |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -2.01 Billion | -4.91 Million | -9.34 Billion | -10.49 Billion | - |
| Sales/Maturities of investments | 1 Billion | 25.32 Million | 11.25 Billion | 10.22 Billion | - |
| Other Investing Activities | 1.1 Billion | 18.04 Million | -379 Million | 32.03 Million | -823.69 Million |
| Financing Cash Flow | 10.53 Billion | 2.03 Billion | -1.02 Billion | -1.63 Billion | 5.36 Billion |
| Debt repayment | -10.86 Billion | -3.26 Billion | -821.05 Million | -731.09 Million | -12.57 Billion |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -62.88 Million | -999.5 Million | - | - | -641.05 Million |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -37.86 Million | -10.00 | -1.1 Million | -647.49 Million | -6.57 Billion |
| Accounts receivables | -1.57 Billion | -1.41 Billion | 806.46 Million | 568.82 Million | 391.16 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | 1.33 Billion | -2.11 Billion | -361.36 Million | -1.61 Billion | 939.67 Million |
| Other working capital | -1.6 Billion | 209.57 Million | 346.81 Million | -229.22 Million | 166.19 Million |
| Cash at beginning of period | 10.8 Billion | 11.99 Billion | 15.04 Billion | 18.87 Billion | 19.17 Billion |
| Cash at end of period | 14.81 Billion | 10.8 Billion | 11.99 Billion | 15.04 Billion | 18.87 Billion |
| Capital Expenditure | -1.12 Billion | -1.06 Billion | -1.18 Billion | -1.68 Billion | -5.73 Billion |
| Effect of forex changes on cash | -214.45 Million | -37.88 Million | -34.25 Million | -649.29 Million | -43.32 Million |
| Net cash flow / Change in cash | 4.01 Billion | -1.18 Billion | -3.05 Billion | -3.83 Billion | -295.27 Million |
| Free Cash Flow | -3.92 Billion | -2.87 Billion | -2.43 Billion | -1.66 Billion | -4.78 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.09 Billion | 700.12 Million | -1.4 Billion | -5.91 Billion | -1.61 Billion | -1.59 Billion |
| Depreciation & Amortization | 651.22 Million | 852.65 Million | 859.6 Million | 3.52 Billion | 867.74 Million | 888.63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 26.88 Million | - | - |
| Change in working capital | -3.43 Billion | 6.96 Million | -382.05 Million | -62.21 Million | -1.21 Billion | 3.23 Billion |
| Other non-cash items | -468.66 Million | 480.11 Million | 364 Million | 1.73 Billion | 505.87 Million | 234.71 Million |
| Investing Cash Flow | -442.11 Million | -1.55 Billion | -1.25 Billion | -3.5 Billion | -1.85 Billion | -603.85 Million |
| Investments in PPE | -188.33 Million | -2.35 Billion | -235.82 Million | -1.12 Billion | -277.93 Million | -172.33 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -1.34 Million | -1.39 Million | -2.01 Billion | -1.37 Million | -1 Billion |
| Sales/Maturities of investments | - | - | - | 1 Billion | - | - |
| Other Investing Activities | -253.78 Million | -22 Million | 4.83 Million | 1.1 Billion | 1.03 Billion | 45.68 Million |
| Financing Cash Flow | 563.53 Million | -5.06 Billion | -6.1 Billion | 10.53 Billion | 14.75 Billion | 945.88 Million |
| Debt repayment | -68.57 Million | -5 Billion | -6.04 Billion | -10.86 Billion | -14.91 Billion | -1 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.16 Billion | -1.71 Million | - | -62.88 Million | -62.88 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.8 Billion | - | -3.99 Million | -37.86 Million | 14.81 Billion | 1 Billion |
| Accounts receivables | -4.05 Billion | -1.24 Billion | -637.23 Million | -1.57 Billion | 418.71 Million | -105.88 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -68.29 Million | 612.2 Million | 1.26 Billion | 1.33 Billion | 296.38 Million | 1.42 Billion |
| Other working capital | 689.68 Million | -351.09 Million | -1.2 Billion | -1.6 Billion | -95.9 Million | -147.06 Million |
| Cash at beginning of period | 10.18 Billion | 14.81 Billion | 24.87 Billion | 10.8 Billion | 13.39 Billion | 10.26 Billion |
| Cash at end of period | 12.14 Billion | 10.18 Billion | 14.81 Billion | 14.81 Billion | 24.87 Billion | 13.39 Billion |
| Capital Expenditure | -188.33 Million | -2.35 Billion | -235.82 Million | -1.12 Billion | -277.93 Million | -172.33 Million |
| Effect of forex changes on cash | -4.53 Million | -1.11 Million | -218.88 Million | -214.45 Million | -18.03 Million | -10.05 Million |
| Net cash flow / Change in cash | 1.95 Billion | -4.63 Billion | -10.05 Billion | 4.01 Billion | 11.48 Billion | 3.12 Billion |
| Free Cash Flow | 1.65 Billion | -366.59 Million | -2.7 Billion | -3.92 Billion | -1.67 Billion | 2.62 Billion |
RMGOF
CLI
UNIENTER
CASTROLIND
GEMSI
CBRG